ORYZON GENOMICS S.A.

Insiders Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Market Closed - BME Other stock markets 09:05:18 25/06/2024 pm IST			5-day change	1st Jan Change
1.88 ^EUR	-0.53%		-0.21%	-0.42%

14/06	Oryzon Genomics S.A. Presents Preliminary Data from Ongoing Phase Ib Frida Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory Flt3-Mut Aml Patients At Eha-2024	CI
06/05	Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oryzon Genomics, S.A. Announces Clinical Candidate Nomination of ORY-4001 for the Treatment of CNS Disorders	13/23/13	CI
Oryzon Genomics S.A. Announces Appointment of Douglas V. Faller as Global Chief Medical Officer	28/22/28	CI
Oryzon Genomics S.A. Appoints Ana Limón as Senior Vice President of Clinical Development and Global Medical Affairs	11/22/11	CI
Oryzon Genomics S.A. Appoints Saikat Nandi Has Been Appointed as Global Chief Business Officer	22/21/22	CI
Oryzon Genomics S.A. Announces Executive Changes	02/20/02	CI
Oryzon Genomics S.A. Announces Board Changes	11/20/11	CI
Oryzon Genomics S.A. Appoints Vanessa Almendro Navarro to Board of Directors	17/20/17	CI
Oryzon Genomics Appoints Michael T. Ropacki as Vice President of Clinical and Product Development	07/19/07	CI
Oryzon Genomics Announces Changes to its Board of Directors	20/18/20	CI
Oryzon Genomics Appoints Lori A. Kunkel as a Scientific Advisor	05/18/05	CI
Oryzon Genomics Announces Executive Changes	16/17/16	CI
Oryzon Genomics Appoints Board of Directors	04/15/04	CI
Oryzon Genomics SA Appoints Greg Weaver as Executive Vice President and Global Chief Financial Officer	12/15/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer